These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 19049391

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
    Romsicki Y, Sharom FJ.
    Biochemistry; 1999 May 25; 38(21):6887-96. PubMed ID: 10346910
    [Abstract] [Full Text] [Related]

  • 3. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
    Shen X, Chen G, Zhu G, Fong WF.
    Bioorg Med Chem; 2006 Nov 01; 14(21):7138-45. PubMed ID: 16875827
    [Abstract] [Full Text] [Related]

  • 4. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA, Airan LE, Germann UA, Ambudkar SV, Pastan I, Gottesman MM.
    Biochemistry; 1998 Sep 29; 37(39):13660-73. PubMed ID: 9753453
    [Abstract] [Full Text] [Related]

  • 5. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R, Katzir H, Yeheskely-Hayon D, Eytan GD.
    FEBS J; 2007 Dec 29; 274(23):6204-14. PubMed ID: 17986257
    [Abstract] [Full Text] [Related]

  • 6. P-glycoprotein (ABCB1) interacts directly with lipid-based anti-cancer drugs and platelet-activating factors.
    Eckford PD, Sharom FJ.
    Biochem Cell Biol; 2006 Dec 29; 84(6):1022-33. PubMed ID: 17215888
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK, Zhu GY, Shen XL, Chattopadhyay A, Dey S, Fong WF.
    Biochem Pharmacol; 2006 Sep 28; 72(7):824-37. PubMed ID: 16889754
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
    Gayet L, Dayan G, Barakat S, Labialle S, Michaud M, Cogne S, Mazane A, Coleman AW, Rigal D, Baggetto LG.
    Biochemistry; 2005 Mar 22; 44(11):4499-509. PubMed ID: 15766280
    [Abstract] [Full Text] [Related]

  • 11. Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: implications for the drug-transport mechanism.
    Zhang M, Wang G, Shapiro A, Zhang JT.
    Biochemistry; 1996 Jul 30; 35(30):9728-36. PubMed ID: 8703944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol.
    Kimura Y, Kioka N, Kato H, Matsuo M, Ueda K.
    Biochem J; 2007 Jan 15; 401(2):597-605. PubMed ID: 17029589
    [Abstract] [Full Text] [Related]

  • 14. Interaction of P-glycoprotein with defined phospholipid bilayers: a differential scanning calorimetric study.
    Romsicki Y, Sharom FJ.
    Biochemistry; 1997 Aug 12; 36(32):9807-15. PubMed ID: 9245413
    [Abstract] [Full Text] [Related]

  • 15. The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids.
    Eckford PD, Sharom FJ.
    Biochem J; 2005 Jul 15; 389(Pt 2):517-26. PubMed ID: 15799713
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.
    Regev R, Assaraf YG, Eytan GD.
    Eur J Biochem; 1999 Jan 15; 259(1-2):18-24. PubMed ID: 9914470
    [Abstract] [Full Text] [Related]

  • 19. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K, Thamboo A, Lee SD, Wasan KM.
    J Pharm Pharm Sci; 2007 Jan 15; 10(3):319-31. PubMed ID: 17727795
    [Abstract] [Full Text] [Related]

  • 20. P glycoprotein and the mechanism of multidrug resistance.
    Váradi A, Szakács G, Bakos E, Sarkadi B.
    Novartis Found Symp; 2002 Jan 15; 243():54-65; discussion 65-8, 180-5. PubMed ID: 11990782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.